Chapter 7Cheminformatics in a Clinical Setting
Matthew D. Krasowski1 and Sean Ekins2
1Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
2Collaborations Pharmaceuticals, Inc., Raleigh, NC, USA
Chapter Menu
- Introduction
- Similarity Analysis Applied to Drug of Abuse/Toxicology Immunoassays
- Similarity Analysis Applied to Therapeutic Drug Monitoring Immunoassays
- Similarity Analysis Applied to Steroid Hormone Immunoassays
- Cheminformatics Applied to “Designer Drugs”
- Relevance to Antibody-Ligand Interactions
- Conclusions and Future Directions
7.1 Introduction
Detection and measurement of drugs, drug metabolites, and steroid hormones in body fluids is commonly used in clinical medicine and forensic science [1–4]. For example, blood concentrations of steroid hormones such as cortisol, estradiol, progesterone, and testosterone assist in the evaluation of endocrinology and reproductive disorders. Detection of anabolic steroids that are potentially abused as performance-enhancing drugs is important in competitive athletics [5, 6]. Therapeutic drug monitoring (TDM) involves determination of serum/plasma concentrations of medications and/or metabolites to guide drug dosing and avoid toxicity [7]. Lastly, drug of abuse and toxicology (DOA/Tox) analyses are used widely in emergency medicine, management of patients on pain medications, competitive athletics, and forensics [8].
The two main technologies for clinical analysis of drug, drug metabolites, and ...
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Read now
Unlock full access